Lithium Versus Anticonvulsants and the Risk of Physical Disorders

NCT06005155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 169285

Last updated 2023-08-22

No results posted yet for this study

Summary

Nationwide population-based register linkage study covering the entire 5.9 million inhabitants in Denmark systematically investigating the associations between sustained long-term use of lithium versus lamotrigine and valproate, and the risk of a range of physical disorders emulating a randomized trial.

Conditions

Interventions

DRUG

Lithium

Sustained long-term exposure

Sponsors & Collaborators

  • Mental Health Services in the Capital Region, Denmark

    lead OTHER

Principal Investigators

  • Lars V Kessing, Professor · Psychiatric Center Copenhagen

Eligibility

Min Age
5 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-07-01
Completion
2023-07-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06005155 on ClinicalTrials.gov